A detailed history of Advisor Net Financial, Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Advisor Net Financial, Inc holds 185 shares of FLGT stock, worth $3,385. This represents 0.0% of its overall portfolio holdings.

Number of Shares
185
Previous 36 413.89%
Holding current value
$3,385
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$19.6 - $25.06 $2,920 - $3,733
149 Added 413.89%
185 $4,000
Q3 2022

Oct 04, 2022

SELL
$37.92 - $63.74 $2,085 - $3,505
-55 Reduced 60.44%
36 $1,000
Q2 2022

Jul 07, 2022

BUY
$47.98 - $62.75 $2,638 - $3,451
55 Added 152.78%
91 $5,000
Q1 2022

Apr 14, 2022

BUY
$49.85 - $96.11 $1,196 - $2,306
24 Added 200.0%
36 $2,000
Q4 2021

Jan 19, 2022

BUY
$77.3 - $105.0 $927 - $1,260
12 New
12 $1,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $554M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.